Cogstate Ltd is a cognitive science company... Show more
The Aroon Indicator for COGZF entered a downward trend on December 31, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 148 similar instances where the Aroon Indicator formed such a pattern. In of the 148 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on January 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COGZF as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 10-day moving average for COGZF crossed bearishly below the 50-day moving average on December 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where COGZF's RSI Indicator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for COGZF just turned positive on December 23, 2025. Looking at past instances where COGZF's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
COGZF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.540) is normal, around the industry mean (22.229). P/E Ratio (26.501) is within average values for comparable stocks, (112.798). COGZF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.473). Dividend Yield (0.009) settles around the average of (0.030) among similar stocks. P/S Ratio (5.291) is also within normal values, averaging (66.670).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COGZF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock slightly better than average.
Industry ServicestotheHealthIndustry
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSVOX | 6.73 | 0.02 | +0.30% |
| Morgan Stanley Vitality Portfolio R6 | |||
| FWOCX | 18.77 | N/A | N/A |
| Fidelity Advisor Women's Leadership C | |||
| IBLLX | 35.27 | -0.03 | -0.08% |
| Transamerica Multi-Managed Balanced C | |||
| BRWUX | 27.93 | -0.07 | -0.25% |
| MFS Blended Research Growth Eq R4 | |||
| JFNIX | 82.14 | -0.24 | -0.29% |
| Janus Henderson Global Life Sciences I | |||
A.I.dvisor tells us that COGZF and PRCH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COGZF and PRCH's prices will move in lockstep.
| Ticker / NAME | Correlation To COGZF | 1D Price Change % | ||
|---|---|---|---|---|
| COGZF | 100% | N/A | ||
| PRCH - COGZF | 24% Poorly correlated | -5.06% | ||
| IMXI - COGZF | 24% Poorly correlated | -0.06% | ||
| LYFT - COGZF | 22% Poorly correlated | -2.23% | ||
| CIOXY - COGZF | 22% Poorly correlated | N/A | ||
| ELWS - COGZF | 21% Poorly correlated | +9.16% | ||
More | ||||
| Ticker / NAME | Correlation To COGZF | 1D Price Change % |
|---|---|---|
| COGZF | 100% | N/A |
| Health Services category (412 stocks) | 1% Poorly correlated | -0.23% |
| Services to the Health Industry category (92 stocks) | 1% Poorly correlated | -0.34% |